Implementation Strategy Training for Liver Cancer
(OASIS Trial)

Recruiting in Palo Alto (17 mi)

Overseen byShari S. Rogal, MD MPH

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: VA Office of Research and Development

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial tests a new decision aid tool that uses machine learning to help healthcare providers choose the best strategies for implementing effective medical practices. The focus is on Veterans with cirrhosis who need cancer screenings. The tool aims to improve screening rates by identifying and overcoming barriers specific to each medical center.

Eligibility Criteria

This trial is for veterans who've had recent medical care at a VA center and have liver cirrhosis or related complications, as well as healthcare providers involved in improving care at these centers. It's not for those who've had a liver transplant or currently have active liver cancer.

Inclusion Criteria

Veterans with two outpatient or one inpatient codes for cirrhosis or its complications who had an encounter in the prior 18 months at a participating VA medical center

Physicians, advance practice providers, nurses, leadership, and staff engaged with selecting and applying implementation strategies to improve care at a participating VA medical center

Exclusion Criteria

I am a veteran who has undergone a transplant.

I am a veteran with active liver cancer.

Participant Groups

Project OASIS is testing a new decision aid tool against the current one to see which better identifies barriers and matches strategies to improve healthcare implementation. This study randomly assigns different VA centers to use either the new or current tool.

2Treatment groups

Experimental Treatment

Active Control

Group I: OASIS DAExperimental Treatment1 Intervention

Half of the sites will be randomized to receive training on the OASIS decision aid.

Group II: Current DA ToolActive Control1 Intervention

Half of the sites will be randomized to receive training on the current decision aid tool.